 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 5 | 1/1 | 返回列表 |
| 查看: 2036 | 回復(fù): 5 | |||
| 本帖產(chǎn)生 1 個(gè) 翻譯EPI ，點(diǎn)擊這里進(jìn)行查看 | |||
| 當(dāng)前只顯示滿足指定條件的回帖，點(diǎn)擊這里查看本話題的所有回帖 | |||
tianya716
|
[交流]
（要明天中午之前）文章摘要翻譯
|
||
|
中文翻譯成英文--翻譯文章的摘要 自己翻譯了一點(diǎn)，但覺(jué)得自己水平太差，需要幫助！ 很急��！因?yàn)槲恼戮鸵蛯徚耍约阂呀?jīng)在上班，時(shí)間太少。 摘要 目的 本課題研制瑞格列奈分散片，目的是提高藥物的生物利用度、提高順應(yīng)性和建立科學(xué)嚴(yán)謹(jǐn)?shù)馁|(zhì)量控制標(biāo)準(zhǔn)。研制的瑞格列奈分散片已經(jīng)轉(zhuǎn)讓與**制藥公司進(jìn)行臨床試驗(yàn)和上市銷售。本文研制的瑞格列奈自微乳膠囊，目的是進(jìn)一步提高藥物的生物利用度和減少藥物可能存在的副作用。 方法（1）瑞格列奈分散片處方和工藝研究 采用單因素試驗(yàn)，以分散均勻性和溶出度為指標(biāo)，對(duì)輔料種類的進(jìn)行篩選；采用正交試驗(yàn)，以分散均勻性、溶出度為指標(biāo)，對(duì)輔料用量進(jìn)行優(yōu)化，并最終確定處方。采用單因素試驗(yàn)對(duì)等量遞增混勻法-濕法制粒工藝、溶劑分散混勻法-濕法制粒工藝和等量遞增混勻法-粉末直接壓片工藝，進(jìn)行比較，優(yōu)選出最佳的工藝。 （2）瑞格列奈分散片含量測(cè)定方法的研究 以回收率和pH耐用性為評(píng)價(jià)指標(biāo)，對(duì)三種瑞格列奈片劑的含量測(cè)定方法進(jìn)行比較，最終確定美國(guó)藥典的瑞格列奈片劑的含量測(cè)定方法較好。并依據(jù)美國(guó)藥典的瑞格列奈片劑的含量測(cè)定方法，建立了瑞格列奈分散片的含量測(cè)定方法。 （3）瑞格列奈分散片溶出度測(cè)定方法的研究 通過(guò)對(duì)瑞格列奈分散片溶出介質(zhì)和轉(zhuǎn)速的篩選，建立了科學(xué)合理的溶出度測(cè)定方法，并對(duì)瑞格列奈分散片進(jìn)行了體外評(píng)價(jià)研究。 （4）瑞格列奈分散片有關(guān)物質(zhì)的研究 通過(guò)酸、堿、熱破環(huán)試驗(yàn)，對(duì)瑞格列奈可能存在有關(guān)物質(zhì)進(jìn)行分離，并通過(guò)二極管陣列檢測(cè)器對(duì)藥物主峰的純度進(jìn)行檢查，建立科學(xué)嚴(yán)謹(jǐn)?shù)娜鸶窳心魏腿鸶窳心畏稚⑵挠嘘P(guān)物質(zhì)的測(cè)定方法。 （5）瑞格列奈分散片的加速穩(wěn)定性考察 對(duì)瑞格列奈分散片進(jìn)行了6個(gè)月的加速穩(wěn)定性試驗(yàn)，并據(jù)此預(yù)測(cè)出藥物的有效期為2年。 （6）瑞格列奈自微乳膠囊的研制 采用正交試驗(yàn)和三元相圖，以溶解度、透光率、粒徑指標(biāo)，篩選瑞格列奈自微乳膠囊的處方，并進(jìn)行質(zhì)量評(píng)價(jià)研究和初步穩(wěn)定性考察。 結(jié)果 （1）瑞格列奈分散片 成功優(yōu)選出瑞格列奈分散片的處方，并建立了科學(xué)嚴(yán)謹(jǐn)?shù)馁|(zhì)量標(biāo)準(zhǔn)。自制瑞格列奈分散片比市售的普通片劑的溶出速率和30min的溶出度均明顯增加，初步達(dá)到提高藥物生物利用度的目的。 （2）瑞格列奈自微乳膠囊 成功優(yōu)選出瑞格列奈自微乳膠囊的處方，并建立了質(zhì)量控制和評(píng)價(jià)標(biāo)準(zhǔn)。瑞格列奈自微乳膠囊，與市售的普通片劑和自制的普通膠囊相比，溶出速率和30min的溶出度均明顯增加，初步達(dá)到提高藥物生物利用度的目的。 結(jié)論 篩選的瑞格列奈分散片和自微乳膠囊的處方合理，制備工藝簡(jiǎn)單可行，質(zhì)量標(biāo)準(zhǔn)能有效控制質(zhì)量。制備的瑞格列奈分散片和自微乳膠囊符合制劑質(zhì)量要求。通過(guò)體外評(píng)價(jià)研究，所研制的瑞格列奈分散片和自微乳膠囊，與市售的普通片劑和普通膠囊相比，溶出明顯加快，初步達(dá)到提高藥物生物利用度的目的。 關(guān)鍵詞：瑞格列奈；分散片；自微乳膠囊；正交試驗(yàn)；質(zhì)量標(biāo)準(zhǔn)；三元相圖；星點(diǎn)-效應(yīng)面設(shè)計(jì) Abstract Objective The purpose of this subject is developping repaglinide dispersible tablets, aims to improve the bioavailability of drugs, improve compliance and the establishment of scientific and strict quality control standards. Repaglinide dispersible tablets have been sold to the U.S. **Zhongshan pharmaceutical company. This article developed the microemulsion capsule of repaglinide, aims to further improve the bioavailability of the drug and reduce drug side effects that may exist. Methods (1) repaglinide dispersible tablets prescription and technology [ Last edited by tianya716 on 2010-5-18 at 18:36 ] |
回復(fù)此樓» 猜你喜歡
083000學(xué)碩274求調(diào)劑
已經(jīng)有6人回復(fù)
-
304求調(diào)劑
已經(jīng)有4人回復(fù)
-
張芳銘-中國(guó)農(nóng)業(yè)大學(xué)-環(huán)境工程專碩-298
已經(jīng)有4人回復(fù)
-
266分，求材料冶金能源化工等調(diào)劑
已經(jīng)有8人回復(fù)
-
085701環(huán)境工程，267求調(diào)劑
已經(jīng)有13人回復(fù)
-
一志愿中南大學(xué)化學(xué)0703總分337求調(diào)劑
已經(jīng)有3人回復(fù)
-
一志愿南昌大學(xué)324求調(diào)劑
已經(jīng)有5人回復(fù)
-
322求調(diào)劑
已經(jīng)有6人回復(fù)
-
320分，材料與化工專業(yè)，求調(diào)劑
已經(jīng)有9人回復(fù)
-
086502化學(xué)工程342求調(diào)劑
已經(jīng)有6人回復(fù)
benmao_mogu
鐵桿木蟲 (著名寫手)
- 翻譯EPI: 51
- 應(yīng)助: 16 (小學(xué)生)
- 金幣: 5474.7
- 散金: 2632
- 紅花: 24
- 帖子: 1539
- 在線: 197.5小時(shí)
- 蟲號(hào): 992763
- 注冊(cè): 2010-04-09
- 性別: GG
- 專業(yè): 化學(xué)反應(yīng)工程
4樓2010-05-18 19:44:50
mmyytiger
至尊木蟲 (職業(yè)作家)
院士
- 翻譯EPI: 7
- 應(yīng)助: 15 (小學(xué)生)
- 金幣: 12669.3
- 紅花: 10
- 帖子: 3246
- 在線: 272.5小時(shí)
- 蟲號(hào): 851420
- 注冊(cè): 2009-09-19
- 性別: GG
- 專業(yè): 計(jì)算機(jī)網(wǎng)絡(luò)
tianya716(金幣+3, 翻譯EPI+1):貌是工具翻譯的 2010-05-18 22:23:13
sirljz:禁止工具直接翻譯的回帖 2010-05-20 17:32:32
sirljz:禁止工具直接翻譯的回帖 2010-05-20 17:32:32
|
Abstract objective The purpose of this subject develop repaglinide, dispersible tablets, aims to improve the bioavailability of drugs, improve compliance and the establishment of scientific and strict quality control standards. Repaglinide dispersible tablets have been developed and ** transfer clinical trials and pharmaceutical companies on sale. This article developed from the microemulsion capsule repaglinide, aims to further improve the bioavailability of drugs and reduce drug side effects that may exist. Methods (1) repaglinide tablet formulation and technology of single factor experiments to spread the uniformity and dissolution rate as an index of the types of screening accessories; orthogonal test, to spread uniformity, dissolution rate for the index for accessories to optimize the dosage and ultimately determine the prescription. Single-factor test and the equivalent incremental mixing method - wet granulation process, solvent dispersion mixing method - wet granulation process and the equal incremental mixing method - the powder pellets technology, comparing the optimized process . (2) Determination of repaglinide tablet study to recovery and durability for the evaluation of pH indicator, the three methods the determination of repaglinide tablets compared to finalize the United States Pharmacopoeia repaglinide Determination tablets better. And according to the United States Pharmacopoeia method for the determination of repaglinide tablets, dispersible tablets was established method for the determination of repaglinide. (3) determination of repaglinide in tablet dissolution studies on repaglinide tablet dissolution medium and the speed of screening, the establishment of a scientific and reasonable method of dissolution test, and repaglinide were dispersible tablets In vitro evaluation. (4) repaglinide tablet related substances by acid, alkali, heat broken ring test, the material on repaglinide may be isolated by diode array detector and the main peak of the purity of the drug inspection, the establishment of rigorous science and repaglinide repaglinide tablet Determination of related substances. (5) the acceleration of dispersible tablets stability of repaglinide on repaglinide tablet was 6 months of accelerated stability test, and to predict the drug is valid for 2 years. (6) repaglinide from microemulsion capsule by orthogonal experiment and the ternary phase diagram, with solubility, light transmittance, particle size index, selection repaglinide from microemulsion capsule formulation, and evaluated the quality of Stability study and preliminary. Results (1) successfully optimized repaglinide repaglinide tablet dispersible tablets prescription, and the establishment of a scientific rigorous quality standards. Home Repaglinide dispersible tablets compared with ordinary commercial dissolution rate and dissolution of 30min were significantly increased, initially to improve drug bioavailability purposes. (2) of repaglinide from microemulsion capsule successfully optimized microemulsion capsules from prescription repaglinide, and the establishment of quality control and evaluation criteria. Repaglinide from microemulsion capsule, and general commercial and home-made capsules, tablets compared, the release rate and the dissolution of 30min were significantly increased, initially to improve drug bioavailability purposes. Conclusion screening repaglinide tablet and capsule from the microemulsion reasonable prescription, preparation is simple and feasible, effective quality control quality standards. Preparation of repaglinide tablet and capsule from the microemulsion formulation meet quality requirements. In vitro evaluation studies, the development of repaglinide in tablet and capsule from the microemulsion, with commercially available conventional tablets and capsules, compared to significantly speed up the dissolution, initially to improve drug bioavailability purposes. Keywords: Repaglinide; tablet; from microemulsion capsule; orthogonal test; quality standards; ternary phase diagram; Star points - response surface design |
2樓2010-05-18 18:44:13
tianya716 
木蟲 (正式寫手)
- 應(yīng)助: 1 (幼兒園)
- 金幣: 7102.4
- 散金: 34
- 帖子: 618
- 在線: 257.1小時(shí)
- 蟲號(hào): 463563
- 注冊(cè): 2007-11-20
- 專業(yè): 藥劑學(xué)
3樓2010-05-18 19:40:32
tianya716
木蟲 (正式寫手)
- 應(yīng)助: 1 (幼兒園)
- 金幣: 7102.4
- 散金: 34
- 帖子: 618
- 在線: 257.1小時(shí)
- 蟲號(hào): 463563
- 注冊(cè): 2007-11-20
- 專業(yè): 藥劑學(xué)
5樓2010-05-18 21:15:50
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 一志愿南昌大學(xué)324求調(diào)劑 +5 | hanamiko 2026-03-27 | 5/250 |
|
|---|---|---|---|---|
|
|
[考研] 086502化學(xué)工程342求調(diào)劑 +6 | 阿姨復(fù)古不過(guò) 2026-03-27 | 6/300 |
|
|
[考研] 085600 286分 材料求調(diào)劑 +5 | 麻辣魷魚 2026-03-27 | 6/300 |
|
|
|
[考研] 291求調(diào)劑 +7 | 孅華 2026-03-22 | 7/350 |
|
|
|
[考研] 352分 化工與材料 +5 | 海納百川Ly 2026-03-27 | 5/250 |
|
|
|
[考研] 0703化學(xué) +6 | 妮妮ninicgb 2026-03-27 | 6/300 |
|
|
|
[考研] 085600，材料與化工321分，求調(diào)劑 +9 | 大饞小子 2026-03-27 | 9/450 |
|
|
|
[考研] 材料學(xué)碩333求調(diào)劑 +8 | 北道巷 2026-03-24 | 8/400 |
|
|
|
[考研] 一志愿陜師大生物學(xué)071000，298分，求調(diào)劑 +5 | SYA！ 2026-03-23 | 5/250 |
|
|
|
[考研] 316求調(diào)劑 +5 | 江辭666 2026-03-26 | 5/250 |
|
|
|
[考研] 341求調(diào)劑 +7 | 青檸檬1 2026-03-26 | 7/350 |
|
|
|
[考研] 329求調(diào)劑 +5 | 1() 2026-03-22 | 5/250 |
|
|
|
[考研] 化學(xué)工程085602 305分求調(diào)劑 +17 | RichLi_ 2026-03-25 | 17/850 |
|
|
|
[考研] 材料科學(xué)與工程 317求調(diào)劑 +4 | JKSOIID 2026-03-26 | 4/200 |
|
|
|
[考研] 0856求調(diào)劑 +8 | zhn03 2026-03-25 | 9/450 |
|
|
|
[考研] 材料專碩 335 分求調(diào)劑 +4 | 拒絕冷暴力 2026-03-25 | 4/200 |
|
|
|
[考研] 生物技術(shù)與工程 +3 | 1294608413 2026-03-25 | 4/200 |
|
|
|
[考研] 一志愿吉林大學(xué)材料與化工303分求調(diào)劑 +4 | 為學(xué)666 2026-03-24 | 4/200 |
|
|
|
[考研] 277分求調(diào)劑，跨調(diào)材料 +3 | 考研調(diào)劑lxh 2026-03-24 | 3/150 |
|
|
|
[考研] 276求調(diào)劑 +3 | YNRYG 2026-03-21 | 4/200 |
|